MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 74 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $949,580 | +307.8% | 30,050 | +233.9% | 0.02% | +400.0% |
| Q2 2023 | $232,830 | +2.0% | 9,000 | -5.3% | 0.00% | -25.0% |
| Q1 2023 | $228,190 | +23.2% | 9,500 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $185,250 | +20.3% | 9,500 | +29.3% | 0.00% | 0.0% |
| Q3 2022 | $154,000 | +710.5% | 7,350 | +635.0% | 0.00% | – |
| Q2 2022 | $19,000 | -56.8% | 1,000 | -50.0% | 0.00% | -100.0% |
| Q1 2022 | $44,000 | -45.0% | 2,000 | -60.0% | 0.00% | 0.0% |
| Q4 2021 | $80,000 | -23.8% | 5,000 | -4.8% | 0.00% | -50.0% |
| Q3 2021 | $105,000 | +101.9% | 5,250 | +75.0% | 0.00% | +100.0% |
| Q2 2021 | $52,000 | +18.2% | 3,000 | +20.0% | 0.00% | 0.0% |
| Q4 2020 | $44,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |